Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25862132
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25862132
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Microvasc+Res
2015 ; 99
(ä): 102-9
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Junctional complex and focal adhesion rearrangement mediates pulmonary
endothelial barrier enhancement by FTY720 S-phosphonate
#MMPMID25862132
Wang L
; Bittman R
; Garcia JG
; Dudek SM
Microvasc Res
2015[May]; 99
(ä): 102-9
PMID25862132
show ga
RATIONALE: Modulation of pulmonary vascular barrier function is an important
clinical goal given the devastating effects of vascular leak in acute lung injury
(ALI). We previously demonstrated that FTY720 S-phosphonate (Tys), an analog of
sphingosine 1-phosphate (S1P) and FTY720, has more potent pulmonary barrier
protective effects than these agents in vitro and in mouse models of ALI. Tys
preserves expression of the barrier-promoting S1P1 receptor (S1PR1), whereas S1P
and FTY720 induce its ubiquitination and degradation. Here we further
characterize the novel barrier promoting effects of Tys in cultured human
pulmonary endothelial cells (EC). METHODS/RESULTS: In human lung EC, Tys
significantly increased peripheral redistribution of adherens junction proteins
VE-cadherin and ?-catenin and tight junction protein ZO-1. Inhibition of
VE-cadherin with blocking antibody significantly attenuated Tys-induced
transendothelial resistance (TER) elevation, while ZO-1 siRNA partially inhibited
this elevation. Tys significantly increased focal adhesion formation and
phosphorylation of focal adhesion kinase (FAK). Pharmacologic inhibition of FAK
significantly attenuated Tys-induced TER elevation. Tys significantly increased
phosphorylation and peripheral redistribution of the actin-binding protein,
cortactin, while cortactin siRNA partially attenuated Tys-induced TER elevation.
Although Tys significantly increased phosphorylation of Akt and GSK3?, neither
PI3 kinase nor GSK3? inhibition altered Tys-induced TER elevation. Tys
significantly increased Rac1 activity, while inhibition of Rac1 activity
significantly attenuated Tys-induced VE-cadherin redistribution and TER
elevation. CONCLUSION: Junctional complex, focal adhesion rearrangement and Rac1
activation play critical roles in Tys-mediated barrier protection in pulmonary
EC. These results provide mechanistic insights into the effects of this potential
ALI therapy.
|Acute Lung Injury/drug therapy/pathology
[MESH]
|Antigens, CD/metabolism
[MESH]
|Antigens, Nuclear/metabolism
[MESH]
|Cadherins/metabolism
[MESH]
|Endothelial Cells/*drug effects
[MESH]
|Fingolimod Hydrochloride/*analogs & derivatives/*therapeutic use
[MESH]